Skip to main content
. 2014 Apr 22;9(4):e95310. doi: 10.1371/journal.pone.0095310

Figure 4. PFS between both treatment arms.

Figure 4

Kaplan-Meier curves depicting progression free survival between sunitinib/docetaxel arm (orange) and docetaxel monotherapy arm (blue). Black bars represent censored patients.